Your browser doesn't support javascript.
Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
Yamamoto, Shohei; Tanaka, Akihito; Oshiro, Yusuke; Ishii, Masamichi; Ishiwari, Hironori; Konishi, Maki; Matsuda, Kouki; Ozeki, Mitsuru; Miyo, Kengo; Maeda, Kenji; Mizoue, Tetsuya; Sugiura, Wataru; Mitsuya, Hiroaki; Sugiyama, Haruhito; Ohmagari, Norio.
  • Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Tanaka A; Department of Laboratory Testing Center, Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Oshiro Y; Department of Laboratory Testing Center, Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Ishii M; Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ishiwari H; Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan.
  • Konishi M; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Matsuda K; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ozeki M; Department of Laboratory Testing Center, Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Miyo K; Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan.
  • Maeda K; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: mizoue@hosp.ncgm.go.jp.
  • Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mitsuya H; Research Institute, National Center For Global Health and Medicine, Tokyo, Japan.
  • Sugiyama H; Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
J Infect ; 83(2): 237-279, 2021 08.
Article in English | MEDLINE | ID: covidwho-1386040

Full text: Available Collection: International databases Database: MEDLINE Main subject: Epidemics / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Year: 2021 Document Type: Article Affiliation country: J.JINF.2021.05.017

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Epidemics / COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Year: 2021 Document Type: Article Affiliation country: J.JINF.2021.05.017